Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Statin Cost Effectiveness Underscored In JAMA Study

This article was originally published in The Pink Sheet Daily

Executive Summary

Study by researchers at Harvard analyzes the cost-effectiveness of statins in patients at low risk of cardiovascular disease under current cholesterol guidelines.

Advertisement

Related Content

Time, And Price, Are Right To Prescribe Statins To the Masses

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register